Here’s the latest healthcare parody video from pharmacy professor James McCormack, as he continues his much-appreciated effort to raise awareness of overscreening, overdiagnosis, and overtreatment in this country.
As usual, this video is full of supporting statistics and excerpts from leading healthcare journals, so take time to pause the video and really understand the information being shared.
I’m all about high-value, evidence-based healthcare.
I’ve written a lot of posts about the problems, including high costs, of overscreening and overtreating. (We spend hundreds of billions of dollars every year on unnecessary healthcare!)
So I love this video by Andrew Lazris, MD, and Erik Rifkin, PhD. They use the visual of 1000 women sitting in a theater to illustrate why screening mammograms are not the life savers many women … read on
I’ve posted before about the limitations of Life Line Screening.
The screening tests they offer in their basic “wellness” package are either not recommended at all because they aren’t effective screening tools (carotid ultrasound), or are not recommended for the general public (abdominal aortic aneurysm ultrasound). Please read my previous post for more information on that: Don’t reach for Life Line Screenings
The high lead levels in Flint, Michigan’s water supply have been news for several months. There’s been a lot of finger pointing and congressional hearings and such, but the bottom line is that because an agency didn’t do its job properly, the health of many kids was put at risk.
Aura Life, the makers of the popular smartphone blood pressure app Instant Blood Pressure, probably made a mistake when they initially used the well-known medical research complex Johns Hopkins in their marketing campaign.
Aura Life boasted their app “uses a patent-pending process developed by a team from the Johns Hopkins University—a world leader in health innovation.”
Baffled, Johns Hopkins sent Aura Life a cease-and-desist letter, but they also decided … read on
PSA stands for Prostate-Specific Antigen. It’s a blood test used to screen for prostate cancer.
Doctors used to recommend an annual PSA test for men over 40. But now we know that the PSA is not a good screening tool. It results in a high number of false positives, and not all forms of prostate cancer need to be treated.